Jodha Tishon, Inc.

Toronto, Ontario M6J 3S3

2 studies enrolling now · 10 studies all time

What they study most

Cataplexy, Depressive Disorder, Major, Excessive Daytime Sleepiness, Excessive Daytime Somnolence, Impaired Cognitive Function, Narcolepsy, Narcolepsy Type 1 (NT 1), Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), OSA, Obstructive Sleep Apnea, Prader-Willi Syndrome

Studies at this site

• A Study of Pitolisant in Patients With Prader-Willi Syndrome — Recruiting now
• A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) — Completed
• Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study — Completed
• An Open Label Study of FT218 in Subjects With Narcolepsy — Completed
• A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1 — Completed
• Continuation Protocol for Obstructive Sleep Apnea (OSA) — Enrolling by invitation
• A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy — Completed
• A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy — Stopped early
• A Study of TAK-994 in Adults With Narcolepsy — Stopped early
• Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder — Stopped early